Literature DB >> 11673847

Activation of the Ah receptor signaling pathway by prostaglandins.

S D Seidel1, G M Winters, W J Rogers, M H Ziccardi, V Li, B Keser, M S Denison.   

Abstract

The aryl hydrocarbon receptor (AhR) is a ligand-dependent transcription factor that mediates many of the biological and toxicological actions of a diverse range of chemicals, including the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin). Although no endogenous physiological ligand for the AhR has yet been described, numerous studies support the existence of such a ligand(s). Here we have examined the ability of prostaglandins and related chemicals to activate the AhR signaling system. Using two AhR-based bioassay systems we report that relatively high concentrations of several prostaglandins (namely, PGB3, PGD3, PGF3alpha, PGG2, PGH1, and PGH2) can not only stimulate AhR transformation and DNA binding in vitro, but also induce AhR-dependent reporter gene expression in mouse hepatoma cells in culture. PGG2 also induced AhR-dependent reporter gene expression to a level three-to four fold greater than that observed with a maximal inducing dose of TCDD. Sucrose gradient ligand binding analysis revealed that PGG2 could competitively displace [3H]TCDD from the AhR. Overall, our results demonstrate that selected prostaglandins are weak agonists for the AhR and they represent a structurally distinct and novel class of activator of the AhR signal transduction pathway. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673847     DOI: 10.1002/jbt.16

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  41 in total

Review 1.  The Aryl Hydrocarbon Receptor: Connecting Immunity to the Microenvironment.

Authors:  Rahul Shinde; Tracy L McGaha
Journal:  Trends Immunol       Date:  2018-11-05       Impact factor: 16.687

2.  Considerations for potency equivalent calculations in the Ah receptor-based CALUX bioassay: normalization of superinduction results for improved sample potency estimation.

Authors:  David S Baston; Michael S Denison
Journal:  Talanta       Date:  2010-11-19       Impact factor: 6.057

3.  Aryl hydrocarbon receptor in breast cancer—a newly defined prognostic marker.

Authors:  Ryoko Saito; Yasuhiro Miki; Shuko Hata; Kiyoshi Takagi; Shinya Iida; Yuki Oba; Katsuhiko Ono; Takanori Ishida; Takashi Suzuki; Noriaki Ohuchi; Hironobu Sasano
Journal:  Horm Cancer       Date:  2014-02       Impact factor: 3.869

4.  Aryl Hydrocarbon Receptor Plays Protective Roles against High Fat Diet (HFD)-induced Hepatic Steatosis and the Subsequent Lipotoxicity via Direct Transcriptional Regulation of Socs3 Gene Expression.

Authors:  Taira Wada; Hiroshi Sunaga; Kazuki Miyata; Haruno Shirasaki; Yuki Uchiyama; Shigeki Shimba
Journal:  J Biol Chem       Date:  2016-02-10       Impact factor: 5.157

Review 5.  Aryl hydrocarbon receptor control of adaptive immunity.

Authors:  Francisco J Quintana; David H Sherr
Journal:  Pharmacol Rev       Date:  2013-08-01       Impact factor: 25.468

Review 6.  The search for endogenous activators of the aryl hydrocarbon receptor.

Authors:  Linh P Nguyen; Christopher A Bradfield
Journal:  Chem Res Toxicol       Date:  2007-12-13       Impact factor: 3.739

7.  Characterization and potential environmental risks of leachate from shredded rubber mulches.

Authors:  Masakazu Kanematsu; Ai Hayashi; Michael S Denison; Thomas M Young
Journal:  Chemosphere       Date:  2009-05-17       Impact factor: 7.086

Review 8.  Role of the aryl hydrocarbon receptor (AhR) in lung inflammation.

Authors:  Celine A Beamer; David M Shepherd
Journal:  Semin Immunopathol       Date:  2013-08-21       Impact factor: 9.623

Review 9.  Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders.

Authors:  Philip B Busbee; Michael Rouse; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Nutr Rev       Date:  2013-04-01       Impact factor: 7.110

10.  Phenotype of the Cyp1a1/1a2/1b1-/- triple-knockout mouse.

Authors:  Nadine Dragin; Zhanquan Shi; Rajat Madan; Christopher L Karp; Maureen A Sartor; Chi Chen; Frank J Gonzalez; Daniel W Nebert
Journal:  Mol Pharmacol       Date:  2008-03-27       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.